Quick Order Cart

Cat. No. ARG1290

MIA3 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The MIA3 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of Raji B lymphocytes carrying loss-of-function mutations in MIA3 (TANGO1), a cargo receptor essential for collagen secretion at ER exit sites. MIA3 recruits COPII components (SEC23A, SEC24C) via cTAGE5 to package large procollagens (COL1A1, COL1A2) into transport vesicles. Knockout of MIA3 disrupts collagen export, leading to ER accumulation and impaired extracellular matrix assembly. This model enables investigation of collagen trafficking, ER stress, and ECM remodeling in disorders like osteogenesis imperfecta and cancer metastasis, and is suitable for secretory pathway drug discovery.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    MIA3

    Gene Identifier

    NCBI Gene ID 375056

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The MIA3 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from Raji B lymphocytes, in which the MIA3 (TANGO1) gene has been disrupted. This heterogeneous pool of knockout cells eliminates MIA3 protein function without clonal selection, offering a robust loss-of-function model. The cells maintain typical lymphoblastoid morphology and proliferation, providing a versatile platform for studying collagen secretion and extracellular matrix biology.

Raji cells are an EBV-positive human B lymphocyte line from a Burkitt’s lymphoma patient, extensively used in immunological and cancer research. Their active secretory pathway and well-characterized signaling make them suitable for investigating ER-to-Golgi transport, despite not being professional collagen secretors. The Raji background enables dissection of COPII-dependent sorting mechanisms in a hematopoietic context.

MIA3/TANGO1 acts as a cargo receptor at ER exit sites, essential for packaging large procollagens into COPII vesicles. It directly binds procollagens (COL1A1, COL1A2, COL7A1) and recruits SEC23A/SEC24C via cTAGE5 to form enlarged carriers. MIA3 expression is regulated by TGFB1, CREB3L2, and ER stress sensors (ATF6), while chaperones like HSPA5/BiP assist loading. Knockout disrupts collagen secretion, causing ER accumulation, ER stress, and ECM defects.

In Raji cells, MIA3 knockout allows study of collagen secretion defects in a non-fibroblastic lineage, highlighting universal ER cargo receptor mechanisms. It provides a model for ER stress induction by procollagen retention and potential B-cell roles in ECM remodeling relevant to lymphoma progression. The cells?? amenability to high-throughput screening suits drug discovery for secretory pathway modulators.

Applications include mechanistic analyses of collagen trafficking, modeling osteogenesis imperfecta, and cancer metastasis research. Assays such as Western blotting, immunofluorescence, pulse-chase, RT-qPCR, and ER stress marker assessment are recommended. Functional studies of cell migration and invasion explore ECM-dependent phenotypes, while electron microscopy examines ER exit site changes. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)